tradingkey.logo

ABPRO Holdings Inc

ABP
4.770USD
-0.030-0.63%
Close 12/24, 13:00ETQuotes delayed by 15 min
12.75MMarket Cap
LossP/E TTM

ABPRO Holdings Inc

4.770
-0.030-0.63%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of ABPRO Holdings Inc

Currency: USD Updated: 2025-12-24

Key Insights

ABPRO Holdings Inc's fundamentals are relatively weak, and its growth potential is high.Its valuation is considered fairly valued, ranking 178/404 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 2.00.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

ABPRO Holdings Inc's Score

Industry at a Glance

Industry Ranking
178 / 404
Overall Ranking
307 / 4562
Industry
Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 1 analysts
Hold
Current Rating
2.000
Target Price
+954.85%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

ABPRO Holdings Inc Highlights

StrengthsRisks
Abpro Holdings, Inc. is a biotechnology company. The Company is advancing a pipeline of next generation antibody therapies for human epidermal growth factor receptor 2 (HER2)+cancers, non-HER2+ gastric and liver cancer, and wet age-related macular degeneration and diabetic macular edema. These antibodies are developed using the Company’s proprietary DiversImmune platform. Its two lead product candidates, ABP-102 and ABP-201, feature its next generation tetravalent antibody format (TetraBi antibody format), which binds to two different targets with two distinct binding sites per target. ABP-102 is designed to redirect a patient’s immune system to fight cancer by engaging T cells through co-targeting HER2, and CD3, T-cell co-receptor. ABP-201 is designed to block blood vessel formation and normalize damaged vessels through co-targeting VEGF and ANG-2. It plans to develop ABP-201 to treat vascular disease of the eye, focusing on wet age-related macular degeneration (Wet AMD).
Growing
The company is in a growing phase, with the latest annual income totaling USD 183.00K.
Overvalued
The company’s latest PE is -0.20, at a high 3-year percentile range.
Held by The Vanguard
Star Investor The Vanguard holds 20.91K shares of this stock.

Financial Health

Currency: USD Updated: 2025-12-24

The current financial score of ABPRO Holdings Inc is 6.32, ranking 276/404 in the Biotechnology & Medical Research industry. Its financial status is weak, and its operating efficiency is low.

Score

Industry at a Glance

Previous score
6.32
Change
0

Financials

3.39

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

7.49

Operational Efficiency

3.16

Growth Potential

10.00

Shareholder Returns

7.55

ABPRO Holdings Inc's Company Valuation

Currency: USD Updated: 2025-12-24

The current valuation score of ABPRO Holdings Inc is 8.14, ranking 63/404 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.20, which is -100.00% below the recent high of 0.00 and -41962.47% above the recent low of -82.48.

Score

Industry at a Glance

Previous score
8.14
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 178/404
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2025-12-24

The current earnings forecast score of ABPRO Holdings Inc is 6.00, ranking 347/404 in the Biotechnology & Medical Research industry. The average price target for ABPRO Holdings Inc is 2.00, with a high of 2.00 and a low of 2.00.

Score

Industry at a Glance

Previous score
6.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 1 analysts
Hold
Current Rating
2.000
Target Price
+954.85%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

534
Total
6
Median
6
Average
Company name
Ratings
Analysts
ABPRO Holdings Inc
ABP
1
CRISPR Therapeutics AG
CRSP
30
argenx SE
ARGX
25
Intellia Therapeutics Inc
NTLA
25
IQVIA Holdings Inc
IQV
25
Ionis Pharmaceuticals Inc
IONS
24
1
2
3
...
107

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-12-24

The current price momentum score of ABPRO Holdings Inc is 6.53, ranking 246/404 in the Biotechnology & Medical Research industry. Currently, the stock price is trading between the resistance level at 6.32 and the support level at 3.84, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.35
Change
0.18

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.235
Sell
RSI(14)
36.318
Neutral
STOCH(KDJ)(9,3,3)
12.820
Oversold
ATR(14)
0.455
Low Volatility
CCI(14)
-79.893
Neutral
Williams %R
89.944
Oversold
TRIX(12,20)
-0.887
Sell
StochRSI(14)
34.208
Sell
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
4.826
Sell
MA10
5.146
Sell
MA20
5.656
Sell
MA50
5.865
Sell
MA100
6.306
Sell
MA200
7.262
Sell

Institutional Confidence

Currency: USD Updated: 2025-12-24

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Abpro Bio International Inc
16.51M
--
Chan (Ian)
9.25M
--
Atlantic Coastal Acquisition Management II LLC
3.48M
--
The Vanguard Group, Inc.
Star Investors
80.56K
--
Suk (Jin Wook)
212.16K
-70.21%
Geode Capital Management, L.L.C.
196.49K
+127.59%
Polar Asset Management Partners Inc.
87.50K
-80.45%
AQR Capital Management, LLC
87.50K
--
1
2

Risk Assessment

Currency: USD Updated: 2025-12-24

The current risk assessment score of ABPRO Holdings Inc is 1.18, ranking 349/404 in the Biotechnology & Medical Research industry. The company's beta value is -0.01. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
1.18
Change
0
Beta vs S&P 500 index
-0.01
VaR
--
240-Day Maximum Drawdown
+87.91%
240-Day Volatility
+385.67%

Return

Best Daily Return
60 days
+17.41%
120 days
+31.67%
5 years
--
Worst Daily Return
60 days
-13.69%
120 days
-21.47%
5 years
--
Sharpe Ratio
60 days
-1.69
120 days
+0.27
5 years
--

Risk Assessment

Maximum Drawdown
240 days
+87.91%
3 years
+100.00%
5 years
--
Return-to-Drawdown Ratio
240 days
+2.80
3 years
-0.18
5 years
--
Skewness
240 days
+2.02
3 years
--
5 years
--

Volatility

Realised Volatility
240 days
+385.67%
5 years
--
Standardised True Range
240 days
+10.94%
5 years
--
Downside Risk-Adjusted Return
120 days
+47.02%
240 days
+47.02%
Maximum Daily Upside Volatility
60 days
+81.95%
Maximum Daily Downside Volatility
60 days
+67.98%

Liquidity

Average Turnover Rate
60 days
+21.06%
120 days
+20.99%
5 years
--
Turnover Deviation
20 days
-100.00%
60 days
-100.00%
120 days
-100.00%

Peer Comparison

Biotechnology & Medical Research
ABPRO Holdings Inc
ABPRO Holdings Inc
ABP
5.73 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Amicus Therapeutics Inc
Amicus Therapeutics Inc
FOLD
8.82 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
IQVIA Holdings Inc
IQVIA Holdings Inc
IQV
8.67 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Dynavax Technologies Corp
Dynavax Technologies Corp
DVAX
8.56 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
BioCryst Pharmaceuticals Inc
BioCryst Pharmaceuticals Inc
BCRX
8.50 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Krystal Biotech Inc
Krystal Biotech Inc
KRYS
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

FAQs

How does TradingKey generate the Stock Score of ABPRO Holdings Inc?

The TradingKey Stock Score provides a comprehensive assessment of ABPRO Holdings Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of ABPRO Holdings Inc’s performance and outlook.

How do we generate the financial health score of ABPRO Holdings Inc?

To generate the financial health score of ABPRO Holdings Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects ABPRO Holdings Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of ABPRO Holdings Inc.

How do we generate the company valuation score of ABPRO Holdings Inc?

To generate the company valuation score of ABPRO Holdings Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare ABPRO Holdings Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of ABPRO Holdings Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of ABPRO Holdings Inc.

How do we generate the earnings forecast score of ABPRO Holdings Inc?

To calculate the earnings forecast score of ABPRO Holdings Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on ABPRO Holdings Inc’s future.

How do we generate the price momentum score of ABPRO Holdings Inc?

When generating the price momentum score for ABPRO Holdings Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of ABPRO Holdings Inc’s prices. A higher score indicates a more stable short-term price trend for ABPRO Holdings Inc.

How do we generate the institutional confidence score of ABPRO Holdings Inc?

To generate the institutional confidence score of ABPRO Holdings Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about ABPRO Holdings Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of ABPRO Holdings Inc.

How do we generate the risk management score of ABPRO Holdings Inc?

To assess the risk management score of ABPRO Holdings Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of ABPRO Holdings Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of ABPRO Holdings Inc.
KeyAI